Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details)

Income Taxes (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Mar. 27, 2020
Income Taxes (Details) [Line Items]      
Statutory income tax rate 21.00% 21.00%  
Valuation allowance amount $ 1,600,000    
Net operating loss carryforwards amount 9,500,000    
Future taxable income $ 3,900,000    
Net operating losses expire description Federal net operating losses generated prior to 2018 and all state net operating losses generated expire in varying amounts beginning in 2037. These net operating losses, generated after 2017, do not expire and will be able to offset 80% of taxable income generated in the future.    
Covid-19 pandemic description     the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. Due to the Company’s history of NOLs, the CARES Act is not expected to have a material impact on the Company’s financial statements.
Amount of benefit rate 50.00%    
Total unrecognized tax benefit $ 101,000 $ 29,000  
Research and Development Expense [Member]      
Income Taxes (Details) [Line Items]      
Net operating loss carryforwards amount 900    
Future taxable income $ 100,000